Possibility of designing better vaccines? Isra Zaman26 July 2023 9:15 AM ISTA new paper in Biology Methods & Protocols, shows it may be possible to design vaccines that will induce a stronger immune response to infecting...
No serious side effects COVID-19 vaccination in young children Isra Zaman7 Jun 2023 9:15 AM ISTA review of more than 245,000 doses of mRNA COVID-19 vaccines given to young children (most of them age 4 and younger) found no indications of serious...
Robust and variable immunity during COVID-19 in pregnant women observed in study Isra Zaman13 April 2023 9:30 AM ISTPregnant women display a strong immune response to SARS-CoV-2 infection, comparable to that of non-pregnant women, new research from the Peter Doherty...
Study finds COVID-19 vaccination linked to fewer cardiac events Isra Zaman22 Feb 2023 10:00 AM ISTResearchers from the Icahn School of Medicine at Mount Sinai have revealed that vaccination against COVID-19 is associated with fewer heart attacks,...
Novel designs of cancer vaccines developed by IIN researchers Isra Zaman2 Feb 2023 9:15 AM ISTA new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for...
Study finds most long covid effects to resolve within an year after mild infection Isra Zaman13 Jan 2023 9:30 AM ISTLong covid is defined as symptoms persisting or new symptoms appearing more than four weeks after initial infection. In March 2022, an estimated 1.5...
Study finds vaccine and prior SARS-CoV-2 infection to confer long-lasting protection against omicron BA.5 Isra Zaman7 Jan 2023 9:30 AM ISTA new study led by Luis Graca, group leader at the Instituto de Medicina Molecular Joao Lobo Antunes (iMM, Lisbon) and full professor at the Medical...
Research shows COVID-19 booster increases durability of antibody response Isra Zaman27 Dec 2022 10:15 AM ISTNew research from the University of VirginiaSchool of Medicine speaks to the benefits of a COVID-19 booster. The new findings shed light on how...
Antiviral drug nirmatrelvir plus ritonavir effective in reducing COVID-19 hospitalization among vaccinated adults 50 and over Isra Zaman16 Dec 2022 9:30 AM ISTThe results of recent clinical trial, now published in Annals of Internal Medicine, suggest that the antiviral drug nirmatrelvir plus ritonavir...
Ebola vaccines safety and immunogenicity trial shows potential Isra Zaman15 Dec 2022 9:15 AM ISTIn a context where many sub-Saharan African countries regularly face Ebola outbreaks, vaccines are seen as a central tool to fight the spread of the...
Penn Scientists develop 20-subtype mRNA flu vaccine to protect against future flu pandemics Dr. Nandita Mohan26 Nov 2022 9:15 AM ISTAn experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in...
New nasal vaccine strategy could improve COVID-19 protection Dr. Nandita Mohan17 Nov 2022 9:00 AM ISTCurrently many vaccines against SARS-CoV-2 have substantially been found to reduce mortality and severe progression of the disease, but protection...
